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Abstract:  
There are many experimental data indicating the correlations of the changes in high 
level of organization of chromatin in human cells and changes in the state of the 
whole organism related to disease, state of tiredness or aging. In our previous work: 
arXiv.org-2018 (1812.00186) we analyzed the publications on the topic up to 2017. 
In this work we focused on works upon the problem of connection of the state of 
chromatin with human diseases published in 2018-2019.  In the modern literature 
the most attention is paid to problem of chromatin transformations in different forms 
of cancer, Alzheimer’s disease, and hereditary diseases. Summing up, the tendency 
of scientific research of noncommunicable diseases is shifting towards investigation 
of aspects of nuclear regulation of disease origin, connected with conformation of 
chromatin. 
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 Introduction  
 Supramolecular organization of chromatin in human cells is connected with the 
state of cell and consequently with the state of the whole organism. Since the 
previous article on the topic: “Chromatin in human cells as characteristics of the 
state of human organism” reviewing the literature mainly up to 2016 (1), some works 
concerning changes in chromatin organization at different diseases have appeared. 
These works are concentrated around the theme “Chromatin structure changes in 
human disease”. Here we present a short review of research works on the topic in 
2017-2019. 
 Discussion  
Several reviews on different aspects of chromatin structure modifications connected 
with human diseases appeared in 2018-2019. General view on alteration of nuclear 
structure connected with hereditary syndromes and cancer one can see in (2). The 
separate section in this review deals with chromatin transformations in disease. 
The role of chromatin rearrangements in the development of nervous system 
development with a special focus on trithorax related proteins. The role of different 
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ATP-dependent chromatin remodeling complexes in in different syndromes, for 
instance, schizophrenia, microcephaly, intellectual disability, and Rett-like 
phenotypes, is also analyzed (3). Also, the precise investigation  of the role of ISWI 
chromatin remodeling complexes is done in connection with brain development 
disorders (4).  
 The review of experimental works investigating molecular events at chromatin level 
connected with Alzheimer’s disease (AD), Huntington’s disease (HD) and 
amyotrophic lateral sclerosis (ALS) is presented in (5). The age-related changes are 
also investigated. The attention of authors of review is focused on histone H3 
modifications: disease-related acetylation and methylation of histone H3.  
Aspects of histone deacetylases (HDACs) possible usage in medical treatment of 
fibrosis–connected diseases are discussed. Deacetylation of histones in chromatin, 
as known, modulates transcriptional activity regulating chromatin compaction. 
Certain types of HDACs are involved in origin of various kinds of fibrosis. Using 
results obtained from animal models authors discuss the possible application of 
HDAC inhibitors in medical treatment of human diseases associated with fibrosis 
(6). 
The role of topoisomerases in chromatin remodeling in disease and normal aging is 
discussed in review (7). The authors focus on two topoisomerases: Top2α, operating 
with double-stranded DNA, and Top3β, changing topology of DNA and RNA. Both 
enzymes are required for normal heterochromatin formation and function.  The 
individuals bearing mutations of Top3β are characterized by the shortened lifespan 
and neurological disorders.  Authors analyze the facts of heterochromatin loss in 
AD, and loss of HP1 or H3K9 methylation in heterochromatin connected to cancer 
progression and tumorigenesis (7). 
The role of deficiency in enzymes modulating chromatin in such diseases as 
retinoblastoma, diabetic retinopathy, glaucoma is demonstrated in (8). 
Chromatin changes at molecular level in human brain associated with AD and aging 
are discussed in (9). An epigenome-wide association study using the histone 3 lysine 
9 acetylation (H3K9ac) mark which marks transcriptionally active open chromatin, 
was done in 669 samples of human prefrontal cortices. Participants of this 
investigation agreed to donate their brain upon death. As accumulation of tau and 
amyloid-β proteins are connected to AD. The acetylation of histone H3 in cortices 
in connection with these protein was performed. In contrast with amyloid-β, tau 
protein accumulation had a broad effect on the epigenome, affecting histone 3 lysine 
9 acetylation. A tau-induced alterations of the histone 3 lysine 9 acetylation were 
much more profound than the changes that are attributable to amyloid pathology. 
The effect of these changes influence the transcriptome. Thus, this work presents 
data on precise localization and distribution of chromatin sites characterized by 
presence of histone 3 acetylated form - H3K9ac. This may be an informative 
approach in research of chromatin state in aging and disease.  
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The informative review on topologically associating domains (TAD) and also 
CCCTC-binding factor (CTCF) binding cites changes in cancer is presented in (10). 
The experimental works demonstrating disruptions of TAD boundaries in case of 
neuroblastoma, medulloblastoma, and leukemia are analyzed. Proposed models are 
discussed, among them: deletion of boundaries resulting in unusual promoter-
enhancer contacts and inversions in TADs alter the contents of neighboring TADs. 
The boundary integrity can be influenced by hyper-methylation of CpG and GC-rich 
CTCF binding motif. This resulted in reducing of CTCF binding in glioma cells. 
Therefore, the data analyzed in this review support the notion of important role of 
TAD changes in cancer. 
In the review paper (11) changes in TAD, connected to limb formation disorders and 
cancer are discussed. In authors view, disrupting TAD boundaries can ectopically 
activate neighboring proto-oncogenes which induce carcinogenesis. 
Several experimental works deal with the role of condensin protein complexes in the 
etiology of diseases is investigated. Chromosome compaction in mitosis is essential 
for their segregation during mitosis. In vertebrates, two condensin complexes ensure 
timely chromosome condensation, sister chromatid disentanglement, and 
maintenance of mitotic chromosome structure (12). The mice bearing mutation in 
gene Ncaph2 coding subunit H2 of condensin II complex, are hypomorphic, have 
reduced brain size, mitoses are characterized by frequent anaphase chromosome 
bridge formation.  Frequent chromosome bridges also observed in mitosis of 
condensin-deficient cells derived from patient with microcephaly bearing mutations 
in condensin I and II subunits genes NCAPD2, NCAPH, and NCAPD3.  
Chromosome bridges formation results in micronucleus formation and aneuploidy 
in daughter cells (12).  
Chromosomal instability is a hallmark of cancer, but mitotic regulators are rarely 
mutated in tumors. Mutations in the condensin complexes, which restructure 
chromosomes to facilitate segregation during mitosis, are significantly enriched in 
cancer genomes, but experimental evidence implicating condensin dysfunction in 
tumorigenesis is lacking. The role of condensin II complex subunit mutation in T-
cell lymphoma is elucidated in (13). Mice with mutations in a condensin II subunit 
(Caph2nes) leads to T-cell lymphoma. Ploidy in such mice was severely perturbed at 
the CD4+CD8+ T-cell stage.  T cells show violations during chromosome 
segregation, resulting DNA damage and elevated ploidy in daughter cells. Tumors 
bearing Caph2 mutation are near diploid but carry deletions spanning tumor 
suppressor genes. P53 inactivation results in proliferation of Caph2 mutant cell lines 
with aneuploidy and structural rearrangements in chromosomes resulting in highly 
aggressive disease. 
A new possible way of chromatin compaction regulation in disease is connected with 
histone glycation (14). In model experiments authors show that glycation by 
methylglyoxal (MGO) at lower concentrations induces relaxation of chromatin fiber, 
while higher MGO concentrations induce their compaction. Authors identify 
glycation of histones in breast cancer cells, xenografts and tumors, but not in normal 
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cultured cells. In authors opinion the obtained results suggest an additional 
pathogenesis-connected mechanism of cellular metabolic damage (14). 
Conclusion  
In recent time (2018-2019) the problem of chromatin activity regulation via its 
conformational transitions in the development of various diseases attracts attention 
of many researchers. The most attention is paid to different forms of cancer, 
Alzheimer’s disease, and hereditary diseases. The most popular methods of 
investigation are connected with genomics and determining of expression of 
enzymes related to chromatin modification, but the methods of TAD investigation 
in disease are also proliferating. Thus, the epigenetic aspects of disease origin, 
connected with conformation of chromatin on supramolecular level are of increasing 
importance. 
 
  
References 
(1) Shckorbatov Y. Properties of Chromatin in Human Cells as Characteristics of 
the State of Human Organism: A Review. arXiv preprint arXiv:1812.00186. 
2018 Dec 1. 
(2) Northcott JM, Weaver VM. Altered Nucleus and Disease. In: Nuclear 
Architecture and Dynamics 2018 Jan 1 (pp. 493-512). Academic Press. 
(3) Moccia A, Martin DM. Nervous system development and disease: a focus on 
trithorax related proteins and chromatin remodelers. Molecular and Cellular 
Neuroscience. 2018 Mar 1;87:46-54. 
(4) Goodwin LR, Picketts DJ. The role of ISWI chromatin remodeling complexes 
in brain development and neurodevelopmental disorders. Molecular and 
Cellular Neuroscience. 2018 Mar 1;87:55-64. 
(5) Berson A, Nativio R, Berger SL, Bonini NM. Epigenetic regulation in 
neurodegenerative diseases. Trends in neurosciences. 2018 Sep 1;41(9):587-
98. 
(6) Yoon S, Kang G, Eom GH. HDAC inhibitors: therapeutic potential in fibrosis-
associated human diseases. International journal of molecular sciences. 2019 
Jan;20(6):1329. 
(7) Lee SK, Wang W. Roles of Topoisomerases in Heterochromatin, Aging, and 
Diseases. Genes. 2019 Nov;10(11):884. 
(8) Popova EY, Barnstable CJ. Insights Into the Epigenetics of Retinal 
Development and Diseases. InEpigenetics and Regeneration 2019 Jan 1 (pp. 
355-383). Academic Press. 
(9) Klein HU, McCabe C, Gjoneska E, Sullivan SE, Kaskow BJ, Tang A, Smith 
RV, Xu J, Pfenning AR, Bernstein BE, Meissner A. Epigenome-wide study 
uncovers large-scale changes in histone acetylation driven by tau pathology 
in aging and Alzheimer’s human brains. Nature neuroscience. 2019 
Jan;22(1):37. 
5 
 
(10)Kaiser VB, Semple CA. When TADs go bad: chromatin structure and nuclear 
organisation in human disease. F1000Research. 2017;6. 
(11)Bruneau BG, Nora EP. Chromatin Domains Go on Repeat in Disease. Cell. 
2018 Sep 20;175(1):38-40. 
(12)Martin CA, Murray JE, Carroll P, Leitch A, Mackenzie KJ, Halachev M, Fetit 
AE, Keith C, Bicknell LS, Fluteau A, Gautier P. Mutations in genes encoding 
condensin complex proteins cause microcephaly through decatenation failure 
at mitosis. Genes & development. 2016 Oct 1;30(19):2158-72. 
(13)Woodward J, Taylor GC, Soares DC, Boyle S, Sie D, Chathoth K, Vukovic 
M, Tarrats N, Jamieson D, Campbell KJ, Blyth K. Condensin II mutation 
causes T-cell lymphoma through tissue-specific genome instability. Genes & 
development. 2016 Oct 1;30(19):2173-86. 
(14) Zheng Q, Omans ND, Leicher R, Osunsade A, Agustinus AS, Finkin-Groner 
E, D’Ambrosio H, Liu B, Chandarlapaty S, Liu S, David Y. Reversible 
histone glycation is associated with disease-related changes in chromatin 
architecture. Nature communications. 2019 Mar 20;10(1):1289. 
